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in ovarian cancer cells†
Christian Seca,‡a Alessandra Ferraresi,‡a Suratchanee Phadngam,ab Chiara Vidonia
and Ciro Isidoro *a
The use of nanoparticles (NPs) for diagnostic and therapeutic purposes involves the risk of side effects due
to the presence of reactive groups on their surface. We studied the cellular stress response to spheroid
fluorescent polystyrene nanoparticles (PS-NPs) functionalized with Amino groups in two ovarian cancer
cell lines differing in the expression, among others, of relevant proteins involved in endocytosis processes
(Caveolin-1) and in pro-survival/pro-death pathways (PTEN and p53). While COOH-PS-NPs were not
toxic, NH2-PS-NPs showed dose- and time-dependent toxicity along with the induction of autophagy.
In OVCAR3 cells, which are PTEN and P53 mutated and deficient in CAV-1, autophagy was insufficient
to protect the cells from NP toxicity. Accordingly, inducers of autophagy were prevented whereas the
silencing of autophagy genes exacerbated NP toxicity. In contrast, in OAW42 cells, which express wild-
type PTEN, P53 and CAV-1, NH2-PS-NPs strongly limited the formation of autophagosomes, along with an
increased production of the mitochondrial anion superoxide and inactivation of ATG4. Preventing the
production of the mitochondrial anion superoxide rescued ATG4-mediated autophagy and saved the cells.
This study outlines the relevance of the genetic background in the autophagy response to toxicity
provoked by NH2-functionalized PS-NPs in cancer cells.
Introduction
Nanoparticles (NPs) engineered with a fluorescent payload
along with magnetic-resonance contrast agents or ultrasound
photoacoustic or metabolic radioactive probes are being tested
for multimodal imaging of cancer cells.1–6 Firstly, the inclusion
of chemotherapeutics makes the NPs able to provide both
imaging and therapeutic functions at the same time.6–9 Such
multifunctional nanoplatforms are called nanotheranostics,
and they can be further functionalized with appropriate ligands
to target specifically the diseased tissue.10,11 The mechanisms
and efficiency of endocytosis, cellular retention and compart-
mentalization and cytotoxic effects of the nanotheranostics
depend on the physical–chemical properties of the NP such
as the shape, the size, the material, and the surface charge.12,13
Besides, the biological effects vary among the cell types.14 The
biological responses to NPs include prompt extrusion,12,15,16
re-localization in other compartments,16–19 production of
ROS,20,21 cell cycle arrest,22,23 cell death and autophagy.24–28
The role of autophagy and the cellular and molecular mecha-
nisms involved in the toxicity elicited in vivo and in vitro by
NPs of different size, charge and material have recently been
reviewed.29,30 Autophagy is a lysosome-driven catabolic process
that maintains cellular homeostasis by degrading harmful
molecules, organelles, particles and excessive or redundant
self-materials.31 It is a stress response triggered by metabolic
imbalance, xenomaterial and oxidative stress.32 Autophagy
starts with the formation of a double-membrane vacuole (called
autophagosome) that entraps the material to be degraded.
Characteristically, both the inner and outer membranes of the
autophagosome are decorated with phosphatidyl-ethanolamine-
conjugated Light Chain 3 (so-called LC3-II isoform), a protein
that is derived from the processing of a microtubule-associated
precursor (MAP-LC3).33 The autophagy substrate is selectively
internalized in the forming autophagosome, thanks to the
bridge between the ubiquitin like p62/SQSTM1 and LC3.34 The
autophagosome eventually fuses with lysosomes to form an
autolysosome, in which the autophagy substrate is degraded by
the acidic hydrolases along with p62/SQSTM1.31 As a controller
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of cell metabolism and tissue homeostasis, autophagy plays a
prominent role in cancer development and progression.35
Ovarian cancer is the most malignant and aggressive gyneco-
logic cancer, claiming each year almost 150 000 deaths among
the affected women in the world (https://seer.cancer.gov/stat
facts/html/ovary.html). Autophagy is involved in ovarian cancer
development and progression.36,37 In principle, nanotherano-
stics could exploit autophagy for therapeutic purposes in ovarian
cancer.25 In this work, we investigated the regulation and the
role of autophagy and ROS production in the cell death pathways
triggered by amino-functionalized (cationic) polystyrene NPs
(NH2-PS-NPs) in ovarian cancer cells. To test the relevance of
the genetic background in the toxic response of cancer cells
versus these NPs, we employed two ovarian cancer cell lines,
OAW42 and OVCAR3, differing in CAV-1, PTEN and TP53 genes,
among others. The involvement and actual role of autophagy
in the stress and toxic responses were investigated through
pharmacologic and genetic manipulations. The aims and experi-
mental design are illustrated in the ESI,† Fig. S1. Though
causing necrotic death in both cell types, we demonstrate the
different effect of NH2-PS-NPs on the autophagy machinery. To
the best of our knowledge, this is the first study showing the
inactivation of ATG4, a protein fundamental to the generation of
autophagosomes, by NH2-PS-NPs. We also demonstrate that this
effect is due to the over-production of the mitochondrial ROS
and that it can be reverted by resveratrol, a polyphenol known for
its anti-oxidant and anticancer properties.
Material and methods
Cell culture
Human ovarian cancer OVCAR3 and OAW42 cell lines were
obtained from ATCC (http://www.lgcstandards-atcc.org) and
cultured under standard conditions (37 1C, 5% CO2) in RPMI
1640 (cod. R8758) or MEM (cod. M2279) medium, respectively,
supplemented with 10% heat-inactivated FBS (cod. ECS0180L;
Euroclone Spa, Milano, Italy), 1% Glutamine (cod. G7513), 1%
non-essential amino acids (cod. M7145) and 1% penicillin and
streptomycin (cod. P0781). Culture media and supplements were
purchased from Sigma Aldrich (Saint Louis, Missouri, USA).
Reagents
Chloroquine (ClQ, cod. C6628; Sigma Aldrich) was dissolved
in sterile water and used at a final concentration of 30 mM.
Rapamycin (Rap, cod. R8781; Sigma Aldrich) was dissolved in
DMSO and used at a 1 mM final concentration. Metformin (Met,
cod. D150959; Sigma Aldrich) was dissolved in sterile water and
used at a 5 mM final concentration. The pan-caspases inhibitor
z-VAD (OMe)-fmk (z-VAD-fmk, cod. 260-020-M005, Alexis Labora-
tories, Farmingdale, NY, USA) was dissolved in DMSO and used at
a 20 mM final concentration. DMSO (final concentration 0.01%)
had no effect on cell growth and autophagy. Resveratrol (RV, cod.
R5010, Sigma Aldrich) was used at a 100 mM final concentration.
Oxalyplatin (cod. 13106, Cayman Chemical Company, Ann Arbor,
MI, USA) was used at a 50 mM final concentration.
Primary antibodies
The following antibodies were used: rabbit anti-LC3 (for WB
1 : 1000; cod. L7543, Sigma Aldrich), mouse anti-LC3 (for IF
1 : 100; cod. 0231-100/LC3-5F10, Nanotools, Teningen, Germany),
rabbit anti-ATG4 (for WB 1 : 500, for IF 1 : 200; cod. 7613, Cell
Signaling, Danvers, MA, USA), mouse anti-b-tubulin (1 : 1000; cod.
T5201, Sigma Aldrich), rabbit anti-p-AKT (Ser473) (1 : 500; cod.
9271, Cell Signaling), rabbit anti-AKT (1 : 500; cod. 4685, Cell
Signaling), rabbit anti-p-S6 (Ser235/236) (1 : 500; cod. 4856, Cell
Signaling), rabbit anti-S6 (1 : 500; cod. 2217, Cell Signaling), rabbit
anti-p-AMPK (Thr172) (1 : 500; cod. 2535, Cell Signaling), rabbit
anti-AMPK (1 : 500; cod. 2532, Cell Signaling), rabbit anti-p62/
SQTM1 (1 : 500; cod. 8025, Cell Signaling), mouse anti-LAMP1
(1 : 1000; cod. 555798, BD, Becton, Dickinson and Company, New
Jersey, NJ, USA), rabbit anti-BAX (1 : 500; cod. 2774, Cell Signaling).
Nanoparticles and Z potential measurement
The following commercial polystyrene nanoparticles (PS-NPs)
were purchased from Sigma Aldrich: 30 nm diameter, carboxy-
functionalized (COOH-PS-NPs), green color emitting (cod. L5155);
50 nm diameter, amine-functionalized (NH2-PS-NPs), blue color
emitting (cod. L0780). The zeta potential of the NPs has been
determined in water suspensions at 25 1C by using a Malvern
Zetasizer NanoZS Instrument (Malvern Panalytical, UK) equipped
with a He–Ne laser with a length of 633 nm. The values were as
follows: NH2-PS-NPs = +37.1  7.9 mV; COOH-PS-NPs = 56.7 
4.7 mV. Similarly, an independent measurement made in a
different laboratory gave the following: NH2-PS-NPs = +35.4 
1.96 mV; COOH-PS-NPs = 52.6  1.82 mV. The Z potential
measured in saline buffer was +17.4  2.19 mV for the former
and 33  0.964 for the latter.
Endocytosis studies
Cells were plated on sterile coverslips and left to adhere for
24 hours, then the medium was replaced, and cells were
incubated with the PS-NPs for the time indicated. To trace
the endocytic pathway, the cells were pre-labeled 10 minutes
before the end of the treatment with 100 nM LysoTracker
Red probe (cod. L7528, Life Technologies Ltd, Paisley, UK).
Coverslips were washed, mounted and immediately imaged
under the microscope.
Cell tracker staining
Cells plated on sterile coverslips and treated with the PS-NPs as
indicated and labeled with the fluorescent dye CellTrackerTM
(CellTrackerTM Blue-CMAC 7-amino-4-chloromethylcoumarin;
cod. C2110, Life Technologies Ltd) as previously reported.38
At the end of treatment, fluorescent dye stained coverslips were
promptly observed using the fluorescence microscope.
Propidium iodide staining
Cells plated on sterile coverslips were treated as indicated.
Necrotic cells were detected by using 0.2 mg ml1 propidium
iodide (PI; incubation for 10 min in the dark at 37 1C; cod.
P4170, Sigma Aldrich). At the end of treatment, fluorescent dye
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stained coverslips were promptly observed using the fluores-
cence microscope.
Assessment of anion superoxide production by MitoSOX
staining
Cells plated on sterile coverslips were treated as indicated.
Mitochondrial superoxide anions were detected in living cells by
using 5 mM MitoSOX-red probe (cod. M36008, Life Technologies
Ltd; incubation for 10 min in the dark at 37 1C). At the end of
treatment, fluorescent dye stained coverslips were promptly
observed using the fluorescence microscope.
Immunofluorescence
The cells plated on sterile coverslips were treated as indicated and
processed for immunofluorescence staining. After cell fixation
with ice-cold methanol and permeabilization with 0.2% Triton-
PBS, coverslips were incubated with specific primary antibodies
overnight at 4 1C (diluted in 0.1% Triton-PBS + 10% FBS). The
following day, coverslips were incubated with dye-conjugated
secondary antibodies (diluted in 0.1% Triton-PBS + 10% FBS)
for 1 hour at room temperature (20–22 1C). The following
secondary antibodies were employed: either IRIS-2 (green
fluorescence)- or IRIS-3 (red fluorescence)-conjugated goat-
anti rabbit IgG or goat-anti mouse IgG (cod. 2W5-08, cod.
2w5-07, cod. 3w5-08, cod. 3w5-07; Cyanine Technology, Torino,
Italy), as appropriate. Nuclei were stained with the UV fluorescent
dye DAPI (40,6-diamidino-2-phenylindole; cod. 32670, Sigma
Aldrich). Coverslips were mounted onto glass using the SlowFade
anti-fade reagent (cod. S36936; Life Technologies, Milan, Italy)
and imaged under the fluorescence microscope.
Transfection of the GFP-LC3 plasmid
Cells were transfected with GFP-LC3 plasmid using lipofectamine
3000 Reagent (cod. L3000-015, Life Technologies), as indicated by
the purchaser. Briefly, OVCAR3 and OAW42 cells were plated on
coverslips at the density of 30 000–40 000 cm2 and left to adhere
for 24 hours before transfection. The DNA loaded liposomal
complexes were prepared in Opti-MEM I Reduced Serum Medium
(cod. 11058021, Life Technologies) with 6 mg of plasmid, 5 ml of
p3000 reagent and 7.5 ml of lipofectamine 3000. After 6 hours
of incubation, the medium was replaced with complete serum-
containing culture medium (10% FBS), and the cells were
cultivated for a further 24 hours to allow the maximal expression
of the transgenic protein prior to any treatment. The plasmid
construct has been reported previously.39
Imaging acquisition and analysis
Fluorescence images were acquired on a Leica DMI600 multi-
channel fluorescence microscope (Leica Microsystems, Wetzlar,
Germany; DMI6000) equipped with motorized focus Z-stacking.
For each experimental condition, at least three slides were
prepared in separate experiments and six to ten microscopic
fields randomly chosen were imaged by two independent
investigators unaware of the treatment. At least 100 to 150 cells
were considered in total. Quantification of fluorescence
intensity was performed using the software ImageJ. Represen-
tative images of selected fields are shown.
Autophagy gene silencing
Post-transcriptional silencing was achieved by using the small
interference RNA (siRNA) technology. Cells were transfected
with siRNA ATG7, siRNA BECLIN-1 or siRNA scrambled using
lipofectamine 3000 Reagent (cod. L3000-015, Life Technologies) as
indicated by the purchaser. The oligonucleotide sequences for the
scramble and siRNA BECLIN-1 have been reported previously.39
The sequence for siRNA ATG7 was as follows: 50-GGG UUA UUA
CUA CAA UGG UGT T-30.
The cells were plated on coverslips and left to adhere for
24 hours before transfection. The DNA loaded liposomal com-
plexes were prepared in Opti-MEM I Reduced Serum Medium
(cod. 11058021, Life Technologies) with 100 pmol of siRNA and
7.5 ml of lipofectamine 3000. After 6 hours, the medium was
replaced with complete serum-containing culture medium
(10% FBS), and the cells were cultivated for a further 24 hours to
allow the maximal gene silencing prior to any treatment. Thereafter,
cells were treated with NPs. The coverslips were stained with
propidium iodide and processed as described above.
Western blotting
Cells were seeded in p35 Petri dishes at the cell density of
40 000–50 000 cell per cm2 and cultured up to approximately
80% of confluence. Cells were washed once with PBS 1X and
harvested with lysis buffer containing 0.2% NADOC and sup-
plemented with protease inhibitor cocktail and phosphatase
inhibitors (50 mM NaF and 1 mM Na3VO4). Bradford assay was
used to measure the protein content. Equal amounts of cell
homogenates (30 mg) were denatured with Laemmli sample
buffer at 95 1C for 10 min, resolved by SDS-PAGE and thereafter
blotted onto the PVDF membrane. The membranes were
blocked with 5% non-fat dry milk + 0.2% Tween for 1 hour at
room temperature, and thereafter incubated with primary
antibodies overnight at 4 1C. The following day, the membranes
were washed and incubated with the secondary antibody (Goat
anti-mouse (cod. 170-6516) or Goat anti-rabbit (cod. 170-6515);
Bio-Rad, Hercules, CA, USA) for 1 hour at room temperature
(20–22 1C). The membranes were washed, and the bands were
detected by using Enhanced Chemiluminescent reagents (ECL;
cod. NEL105001EA; PerkinElmer Inc., Waltham, MA, USA)
and imaged using the VersaDOC Imaging System. For loading
control, the membranes were re-probed with b-tubulin or
b-actin. Intensity of the bands was estimated via densitometry
using Quantity One software.
Statistical analysis
Statistical analysis was performed using the GraphPad Prism
5.0 software. The Bonferroni’s multiple comparison test after
one-way ANOVA analysis (unpaired, two-tailed) was employed.
Significance was considered as follows: ****p o 0.0001;
***p o 0.001; **p o 0.01; *p o 0.05. All experiments have been
reproduced at least three times in separate and independent
replicates. All data are reported as average  S.D.
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Results
1. NH2-PS-NPs induce caspase-independent necrotic cell
death in ovarian cancer cells
In the first set of experiments, the cells were incubated for
increasing times with two doses of PS-NPs and uptake and
toxicity were assessed by fluorescence visualization. Images
shown (in the ESI,† Fig. S2A) indicate that both COOH-
or NH2-functionalized PS-NPs were initially up-taken via the
endocytic pathway labeled with Lysotracker and thereafter
redistributed in the cytoplasm. As indicated by Cell Tracker
staining (ESI† Fig. S2), 50 mg ml1 COOH-PS-NPs (anionic
charged) was not toxic to either OAW42 or OVCAR3 cells when
incubated for up to 24 h, whereas 25 and 50 mg ml1 NH2-PS-
NPs (cationic charged) were revealed to be toxic for both
cell types. Toxicity was slightly apparent at 6 h and extensive
at 24 h when the cells were exposed to 50 mg ml1 NH2-PS-NPs
(Fig. S2B, ESI†). This prompted us to further investigate the
toxic mechanisms of NH2-PS-NPs in the two cell types. To assay
whether toxicity resulted from apoptosis and/or necrosis, the
cells were incubated with 25 and 50 mg ml1 NH2-PS-NPs for
16 h in the absence or the presence of the pan-caspase inhibitor
zVAD-fmk. The cells were then directly (without prior fixation)
stained with propidium iodide (that stains the DNA of necrotic
cells) and immediately imaged under the fluorescence micro-
scope. The images in Fig. 1 indicate that NH2-PS-NPs induced a
caspase-independent necrotic-type death in both cell types. As
proof that the apoptotic machinery was effective in these cells,
we checked for the induction of BAX oligomerization40 upon
exposure to oxalyplatin, a drug widely used in the chemotherapy
of ovarian cancers. The images in Fig. S3 (ESI†) show that in
both OVCAR3 and OAW42 cells, this drug, but not NH2-PS-NPs,
triggers BAX-mediated apoptosis.
2. NH2-PS-NPs induce the autophagy flux in OVCAR3 cells
We employed GFP-LC3 expressing cells to investigate whether
autophagy was triggered as a stress response to NH2-PS-NPs.
Fig. 1 NH2-PS-NPs induce caspase-independent necrotic-type cell death. Cells were plated on sterile coverslips and left to adhere for 24 hours. Then,
cells were incubated without (CO, control) or with 25 mg ml1 or 50 mg ml1 NH2-NPs in the presence/absence of the pan-caspase inhibitor z-VAD-fmk
for 16 hours. Propidium iodide (PI) was added 10 minutes before the end of the treatment and incubated at 37 1C in the dark. Coverslips were washed and
mounted on glass and imaged immediately on the fluorescence microscope. Staining was performed in OVCAR3 cells (A) and in OAW42 cells (B).
Cell death was assessed by counting the percentage of PI positive cells and is represented in the histograms (%  SD). On average, a minimum of
100–150 cells were counted in randomly chosen fields by two independent investigators. Significance was considered as follows: ***p o 0.001;
**p o 0.01; *p o 0.05. All experiments have been reproduced at least three times in independent replicates.
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In control cells not exposed to NPs, GFP fluorescence is diffused in
the cytoplasm (as expected when autophagy is not active), while
upon exposure to NPs, GFP fluorescence is scattered in spots
indicative of LC3 recruitment in the membranes of autophagosomes
(Fig. 2A). A large portion of GFP spots overlapped with blue
fluorescence, suggestive of co-localization of NH2-PS-NPs with
autophagosomes (Fig. 2A, merged channels). To further sub-
stantiate the induction of autophagy by the NPs, the cells were
fixed and immunostained for LC3 and ATG4 (the latter is the
cysteine protease that processes LC3-I). As shown in Fig. 2B, the
expression and the co-localization of LC3 and ATG4 were greatly
stimulated in the cells exposed to NH2-PS-NPs. In addition, the
level of p62/SQSTM1 decreased in the cells exposed to the NPs,
indicative of stimulation of the autophagy flux (Fig. 2C). It
should be noted that in control cells, p62 localizes in the
cytoplasm, as indicated by the lack of co-localization with the
lysosomal marker LAMP1 (Fig. 2C). To definitively prove the induc-
tion of autophagosomes by NH2-PS-NPs, the homogenate of cells
incubated with NPs was used to assay the conversion of LC3-I into
LC3-II by western blotting. In this experiment, chloroquine (ClQ)
Fig. 2 NH2-PS-NP toxicity in OVCAR3 cells associated with increased autophagy. OVCAR3 cells were plated on sterile coverslips and left to adhere.
(A) The following day, cells were transfected with the plasmid encoding GFP-LC3 and then were incubated with 25 mg ml1 or 50 mg ml1 NH2-NPs
for 16 hours. Control (CO) cells were not exposed to the NPs. Autophagy induction was quantified by counting GFP-LC3 spots by using ImageJ software.
Data representing three independent experiments are reported in the histogram as an average (A.U.  SD). Significance was considered as follows:
***p o 0.001; **p o 0.01; *p o 0.05. (B) Cells were incubated without (CO, control) or with 25 mg ml1 or 50 mg ml1 NH2-NPs for 16 hours. Coverslips
were immunofluorescence double stained for LC3 (green) and ATG4 (red). (C) Cells were treated as in panel C and the coverslips were immuno-
fluorescence double stained for p62 (green) and LAMP1 (red). Images are representative of three independent experiments.
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was included to discriminate between the newly produced and
accumulated undegraded LC3-II.41 Data in Fig. 3A demonstrate
the increased accumulation of newly produced LC3-II in the
cells exposed to NH2-PS-NPs. Further, the expression of ATG4
also increased upon exposure to the NPs (Fig. 3B). Finally, we
analyzed the expression and activation status of the two major
pathways controlling autophagy and cell survival under stress,
i.e. the AKT-mTOR and AMPK pathways. The data shown
in Fig. S4 (ESI†) indicated that NH2-PS-NPs switch off the
AKT-mTOR pathway and switch on the AMPK pathway, consistent
with the induction of autophagy as a stress response. Taken
together, these data confirm the induction of autophagy and of
the autophagy flux by NH2-PS-NPs in OVCAR3 cells.
3. Genetic inhibition of autophagy exacerbates whereas
pharmacologic enhancement of autophagy prevents NH2-PS-NP
toxicity in OVCAR3 cells
Next, we investigated the functional role of autophagy in the
cells exposed to NH2-PS-NPs. To this end, we manipulated the
intrinsic level of autophagy and tested the cytotoxic response to
NH2-PS-NPs. First, we silenced two autophagy-related (ATG)
genes, namely BECLIN-1 and ATG7, and then exposed the cells
to NH2-PS-NPs and assayed cell death by PI staining. As shown
in Fig. 4, in the ATG-specific siRNA-transfected cultures, the
number of PI-positive necrotic cells was much higher than in
control sham-transfected cultures. The efficient gene silencing
and down-regulation of autophagy in the cells transfected with
Fig. 3 NH2-PS-NPs promote autophagy flux and ATG4 activation. OVCAR3 cells were incubated with 25 mg ml
1 or 50 mg ml1 NH2-NPs in the
presence/absence of chloroquine (ClQ) for 16 hours. (A) Autophagy flux modulation was monitored by following the LC3-I to LC3-II conversion.
(B) ATG4 expression levels were assessed by Western Blotting. Densitometric analyses of LC3 (upper panel) and of ATG4 (lower panel) were performed
using QuantityOne software. Data are presented in the histograms as an average (in A.U., arbitrary units) SD. All data are representative of three
independent experiments. Significance was considered as follows: ****p o 0.0001.
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siRNA BECLIN-1 or siRNA ATG7 were ascertained in parallel
cultures (not shown).
In a second set of experiments, we stimulated autophagy by
treating the cells with rapamycin, an inhibitor of mTORC1,42 or
with metformin, an inducer of the AMPK pathway.43 These
drugs effectively enhanced the intrinsic level of autophagy, as
demonstrated by the increased expression and co-localization
of LC3 and ATG4 and concomitant reduced accumulation
of p62 (Fig. 5A and B). Upon exposure to NH2-PS-NPs, the
number of PI-positive necrotic cells found in the rapamycin-
or metformin-treated cultures was much lower than that in the
untreated culture exposed to the same concentration and for
the same period to the NPs (Fig. 5C). Taken together, these data
indicate that in OVCAR3 cells, the NH2-PS-NPs induce pro-
survival autophagy, which is however insufficient to prevent
toxicity.
4. NH2-PS-NPs inhibit the formation of autophagosomes in
OAW42 cells
Next, we checked whether NH2-PS-NPs elicited similar modu-
latory effects on autophagy in OAW42 cells. To our surprise, in
these cells, NH2-PS-NPs instead inhibited autophagy, more
particularly at the very early step of autophagosome formation.
This was evident in cells transiently expressing the GFP-LC3
chimeric protein (Fig. 6A) and by immunofluorescence staining
of autophagy proteins (Fig. 6B and C). A strong reduction in the
expression of LC3 (Fig. 6B) and the parallel accumulation of
undegraded p62 (Fig. 6C) were observed. These data were
corroborated by the western blotting of LC3 that revealed
a strong reduction in the generation of LC3-II in the cells
exposed to NH2-PS-NPs (Fig. 6D). We then checked whether
the signaling pathways governing autophagy in OAW42 cells
were inactivated by the NH2-PS-NPs. While the AKT-mTOR
pathway was completely switched off (Fig. S5A, ESI†), contrary
to what was observed in OVCAR3 cells, the AMPK pathway was
(partially) down-regulated (Fig. S5B, ESI†).
5. Pharmacological enhancement of autophagy attenuates
NH2-PS-NP toxicity in OAW42 cells
Given the findings above showing a pro-survival effect of
autophagy, we reasoned that stimulating this process could
protect OAW42 cells from NH2-PS-NP toxicity. Therefore, the
cells were pre-treated with rapamycin or metformin and then
exposed to the NPs. These treatments effectively enhanced
autophagy as demonstrated by the increased immunostaining
of LC3 and ATG4 and concomitant reduced accumulation of
p62 in OAW42 cells (Fig. 7A and B). As shown in the images
in Fig. 7C, in the rapamycin- or metformin-treated cultures,
NH2-PS-NPs-induced necrosis was greatly prevented.
6. NH2-PS-NP toxicity in OAW42 cells is associated with
mitochondrial anion-superoxide inactivation of ATG4
Finally, we investigated the possible mechanism underlying
the inhibition of autophagosome formation by NH2-PS-NPs.
We focused on ATG4 that is among the principal effectors in
the generation of LC3-II.44 The western blotting analysis
showed that the cellular expression of ATG4 was greatly
decreased upon prolonged exposure to the NPs (Fig. 8A). Since
ATG4 is a redox-sensitive cysteine-protease, we wondered
whether its inactivation, and possibly de-stabilization, was
associated with the abnormal production of pro-oxidant species.
Based on literature data and on our previous experience,45,46 we
focused on the generation of anion superoxide at the mitochon-
drial level. The images in Fig. 8B indeed show that NH2-PS-NPs
greatly triggered the production of mitochondrial anion
superoxide.
7. Preventing the production of mitochondrial anion-
superoxide rescues ATG4-dependent autophagy and saves
OAW42 cells from NH2-PS-NP toxicity
In a separate study, we found that the polyphenol resveratrol
(RV; 3,4,5-trihydroxylstibene) could restore ATG4 function
Fig. 4 Silencing of autophagy genes exacerbates NH2-PS-NP toxicity in
OVCAR3 cells. OVCAR3 cells were transfected with siATG7 or siBECLIN-1
for 36 hours and incubated without (CO, control) or with 25 mg ml1 or
50 mg ml1 NH2-NPs for 16 hours. At the end of the treatment, propidium
iodide (PI) staining was performed. Coverslips were washed, mounted
and immediately imaged using the fluorescence microscope. Necrosis
was assessed by counting the percentage of PI positive cells and the
quantification is presented in the histogram (%  SD). On average, a
minimum of 100–150 cells were counted in randomly chosen fields by
two independent investigators. Significance was considered as follows:
****p o 0.0001. All experiments have been reproduced at least three
times in independent replicates.
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Fig. 5 Over-stimulation of autophagy protects OVCAR3 cells from NH2-PS-NP toxicity. (A and B) OVCAR3 cells adhered on coverslips were incubated
with 1 mM rapamycin or 5 mM metformin for 8 and 24 hours. CO indicates control (untreated) cultures. Two different immunofluorescence double
staining methods were performed: LC3 (green) – ATG4 (red) and p62 (green) – LAMP1 (red), shown in panel A and B, respectively. (C) OVCAR3 cells were
pre-treated with 1 mM rapamycin or 5 mM metformin for 8 hours followed by the incubation with 25 mg ml1 NH2-NPs for 16 hours. CO indicates control
(untreated) cultures. At the end of the incubation, cells were stained with propidium iodide (PI). Cell toxicity was quantified by counting the percentage of
PI positive cells. Representative data from three independent experiments are shown in the histogram (%  SD). On average, a minimum of 100–150 cells
were counted in randomly chosen fields by two independent investigators. Significance was considered as follows: ****p o 0.0001.
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and protective autophagy in neuronal-like cells subjected to
oxidative stress.47 Here, we found that when the cells were
exposed to the NPs in the presence of RV, the production of
anion superoxide was greatly attenuated (Fig. 9A), necrotic cell
death was largely prevented (Fig. 9B) and ATG4-dependent
autophagy was strongly induced (Fig. 9C).
Fig. 6 NH2-PS-NP toxicity in OAW42 cells associated with decreased autophagy. (A) OAW42 cells transfected with the GFP-LC3 plasmid were incubated with
25 mg ml1 or 50 mg ml1 NH2-NPs for 16 hours. CO indicates control (untreated) cultures. Autophagy modulation was estimated by counting GFP-LC3 spots in
at least 100 cells in randomly chosen fields using ImageJ software. Data representing three independent experiments are reported in the histogram (A.U. SD).
Significance was considered as follows: ***p o 0.001; **p o 0.01. (B and C) OAW42 cells were incubated with 25 mg ml1 or 50 mg ml1 NH2-NPs for 16 hours.
CO indicates control (untreated) cultures. Cells were immunofluorescence double stained: LC3 (green) – ATG4 (red) and p62 (green) – LAMP1 (red),
respectively shown in panels B and C. (D) OAW42 cells were exposed to 25 mg ml1 or 50 mg ml1 NH2-NPs in the presence/absence of chloroquine (ClQ) for
16 hours. The autophagy flux was monitored by the maturation of LC3-I to LC3-II by Western Blotting analysis. Densitometric analysis of LC3 of three
independent experiments is included. Data are presented as an average (in A.U., arbitrary units) SD. Significance was considered as follows: ****p o 0.0001.
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Fig. 7 Over-stimulation of autophagy protects OAW42 cells from NH2-PS-NP toxicity. (A and B) OAW42 cells were treated with 1 mM rapamycin or
5 mM metformin for 8 and 24 hours. CO indicates control (untreated) cultures. Cells were stained for immunofluorescence labeling of LC3 (green) –
ATG4 (red) or p62 (green) – LAMP1 (red), as indicated in panels A and B, respectively. (C) OAW42 cells were pre-treated with 1 mM rapamycin or 5 mM
metformin for 8 hours followed by the incubation with 25 mg ml1 NH2-NPs for 16 hours. CO indicates control (untreated) cultures. To analyze cell death,
the cells were stained with propidium iodide (PI) and immediately imaged using the fluorescence microscope. The amount of PI positive cells is shown in
the histogram (%  SD). On average, a minimum of 100–150 cells were counted in randomly chosen fields by two independent investigators.
Representative data shown are obtained from three independent replicates. Significance was considered as follows: ****p o 0.0001.
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Discussion
Despite the efforts made for an early diagnosis, ovarian cancer is still
diagnosed too late, when it is already spread in the peritoneum and
distant sites.48 Once diagnosed, the therapeutic options include
surgery, if the tumor is still operable, and chemotherapy.49 However,
ovarian cancers soon develop chemo-resistance and relapse, which
makes this malignant tumor the fifth most common cause of cancer
deaths in women worldwide.50 Nanomedicine can be promising in
the management of ovarian cancer.51 Fluorescent nanoprobes for
the early diagnosis and image-guided surgery of ovarian cancer
may improve prognosis through a more refined staging and
cytoreductive debulking.8,43,52 Furthermore, NPs encapsulating a
chemotherapy drug or siRNA targeting anti-apoptotic protein
represent new weapons that can overcome the drug resistance
in ovarian cancer.53–56 When designing nanotheranostics for
cancer, a great effort is made to choose the most biocompatible
material. However, it is intuitive that, besides the nanomaterial
used, the genetic, epigenetic and metabolic status of the cell
influences the response to the NP. Most of the publications in
nanomedicine focus on the intrinsic properties of the NP, while
paying less attention to the contribution of the intrinsic cell
properties in the cellular response. The present work aimed at
filling, though partially, this gap of knowledge.
Fig. 8 Inhibition of autophagy caused by NH2-PS-NPs in OAW42 cells associated with ATG4 degradation and mitochondrial anion superoxide
production. (A) OAW42 cells were treated with 25 mg ml1 or 50 mg ml1 NH2-NPs for 16 hours. Cell homogenates were analyzed by Western Blotting for
ATG4 expression. Densitometric analysis was performed using the QuantityOne software. Data are presented in the histograms as an average (in A.U.,
Arbitrary Units) SD. Significance was considered as follows: ****p o 0.0001; ***p o 0.001. (B) OAW42 cells adhered on coverslips were exposed
to 25 mg ml1 or 50 mg ml1 NH2-NPs for 16 hours. CO indicates control (untreated) cultures. At the end, cells were stained with MitoSOX, which reveals
the presence of mitochondrial anion superoxide. Representative images shown from three separated experiments were taken using the fluorescence
microscope. The quantification of fluorescence intensity (INT.DEN. average  SD) was performed using the ImageJ software.
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Here, we used NPs made of polystyrene. This material has
been used for the development of nanotheranostics.57,58 In
addition, the availability of charged PS-NPs embedded with a
fluorescent probe makes these NPs a valid tool for monitoring
the uptake and toxicity at the cellular level.15–17,59–61 Thus,
PS-NPs can be used as a paradigm for in vitro investigation of
Fig. 9 Inhibition of mitochondrial ROS production by resveratrol restores ATG4-mediated autophagy and prevents cell death in OAW42 cells exposed
to NH2-PS-NPs. OAW42 cells adhered on coverslips were exposed to 25 mg ml
1 or 50 mg ml1 NH2-NPs for 16 hours in the absence or presence of
resveratrol (RV). CO indicates control (untreated) cultures. At the end, cells were stained with MitoSOX (panel A), or with Propidium Iodide (PI, panel B;
quantification of necrotic cells is included), or fixed and immunofluorescence stained for LC3 and ATG4 (panel C). Representative images shown from
three separated experiments were taken using the fluorescence microscope.
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the mechanisms of toxicity. In agreement with our previous
observations,17 we found that NH2-PS-NPs (50 nm in diameter)
were toxic, whereas COOH-functionalized PS-NPs (30 nm in
diameter) were not, to ovarian cancer cells. Though a direct
comparison cannot be made because of the slight difference in
the diameter of the PS-NPs used here, it seems that (in our
experimental model) the surface charge, not the material, mainly
affects the cell fate. Consistently, NH2-PS, not COOH-PS, NPs
were shown to be cytotoxic in other cell types.60,62,63 For
instance, both COOH- and NH2-PS-NPs of 50 nm were able to
induce autophagy in HeLa cells, though the former were not
toxic when administered at 50 mg ml1 for 24 h while the latter
were toxic when administered at as low as 10 mg ml1 for 24 h.63
In our study, NH2-PS-NPs (50 nm diameter) caused extensive
necrosis when administered at 50 mg ml1 for 16 h both in
OAW42 and OVCAR3 cells. Though both cell lines could trigger
BAX-dependent apoptosis in response to the chemotherapeutic
drug oxaliplatin, this pathway was not activated by NH2-PS-NPs.
On dissecting the mechanisms of toxicity, we found that the
cellular stress response to NH2-PS-NPs manifested as autophagy
was different in OVCAR3 and OAW42 cells, being induced in the
former and inhibited in the latter. With respect to the two major
pathways controlling autophagy and cell survival under stress,
i.e. the AKT-mTOR and AMPK pathways, it was found that in
both cell lines, NH2-PS-NPs totally switched off the AKT-mTOR
pathway, consistent with the induction of autophagy as a stress
response and with a previous report.23 Yet, the AMPK pathway
was strongly induced in the OVCAR3 cells (thus reinforcing the
induction of autophagy) while it was (partially) down-regulated
in OAW42. Several reports have shown that autophagy and cell
death are triggered on treatments with a variety of nanomaterials
(reviewed in ref. 29 and 30). Induction of autophagy and cell
death by PS-NPs has been reported in other cell models.64
Segatori and co-workers have shown that induction of autophagy
by PS-NPs is associated with the nuclear translocation of TFEB, a
transcription factor for several autophagy genes.62 These authors
also found that COOH-PS-NPs stimulated autophagy degrada-
tion, while NH2-PS-NPs caused lysosomal dysfunction and even-
tually impaired the autophagy flux.62
To our knowledge, this is the first report showing that, at
least in some cell types, NPs can instead inhibit autophagy at
the very early step of autophagosome formation.
Autophagy is per se a pro-survival pathway, aimed at removing
damaged and potentially harmful proteins and organelles, as
well as at preventing ROS generation and DNA and protein
damages.32 There is a complex cross-talk between autophagy,
apoptosis and necroptosis, in which autophagy may prevent or
facilitate cell death depending on the type and intensity of the
stimulus as well as the genetic/epigenetic/metabolic status of the
target cells.65 In this cross-talk, a critical role is played by ROS,
which might affect the autophagy machinery.45,66 Here, we
found that NH2-PS-NPs were toxic to OVCAR3 despite the
induction of autophagy. We could demonstrate that autophagy
was indeed protective, yet insufficient. In fact, when induction
of autophagy was prevented by BECN1 or ATG7 gene silencing,
the toxicity induced by NH2-PS-NPs was greatly enhanced.
Conversely, the hyper-stimulation of autophagy with rapamycin
or metformin largely protected OVCAR3 from NH2-PS-NP toxicity.
In contract, NH2-PS-NPs inhibited autophagy in OAW42 cells, and
this was the reason for the occurrence of necrosis. In fact, here
again, rapamycin and metformin elicited protection from NH2-PS-
NP toxicity. It was found that these NPs inhibited the generation of
the lipidated LC3-II isoform needed for autophagosome formation,
and this was associated with a reduced expression of ATG4, the
enzyme responsible for processing LC3.33 Searching for a mecha-
nistic explanation, we focused on the mitochondrial production
of ROS that could account for ATG4 dysfunction based on our
previous studies.46,66 We found that NH2-PS-NPs greatly trig-
gered the production of mitochondrial anion superoxide in
OAW42 cells. To demonstrate that indeed this is the mechanism
through which ATG4 is inactivated, we used RV, an inhibitor of
mitochondrial anion superoxide production that was previously
shown to rescue ATG4-mediated protective autophagy.47 RV was
shown to be able to scavenge hydroxyl (OH) and anion super-
oxide (O2
),67 to inhibit NAD(P)H:quinone oxidoreductase 2
(NQO2; also called QR2),68 and to induce autophagy by activating
the AMPK pathway.69 The data showed that in fact RV could
protect OAW42 cells from NH2-PS-NPs by inhibiting the produc-
tion of mitochondrial anion superoxide and thus restoring the
ability to form ATG4-mediated LC3-positive autophagosomes.
Conclusions
Nanomedicine has the ambition to allow the diagnosis and therapy
of diseases using NPs complexed with reporter molecules and
drugs. The medical use of NPs bears the risk of side effects caused
by unwanted cytotoxicity associated with the physical–chemical
characteristics of the NPs, especially the material, the size and
the presence of the charged group on the surface. Also, the intrinsic
characteristics of the target cell will determine the type and
consequences of the stress response elicited by the NPs.
The present data provide a proof of principle that NH2-
functionalized PS-NPs elicit a differential response in terms of
autophagy regulation in cancer cells having a different genetic
background. Intriguingly, toxicity from NH2-PS-NPs was the con-
sequence of insufficient induction of protective autophagy in one
cell type, and of impairment of autophagosome formation in
another cell type. These findings point to the necessity of a better
assessment of the genetic/epigenetic and metabolic status of the
target cells when designing theranostics for cancer therapy, in
complete agreement with the principle of personalized medicine.
We propose that such assessment should include the genes and
pathways impinging on the autophagy process.
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